MyTomorrows, the Netherlands-headquartered startup that has built a platform to help physicians and patients access drugs that are still in development, has raised €10 million in further funding. Leading the round is EQT Ventures, and Octopus Ventures, with participation from existing backers Balderton Capital, and Sofinnova Partners. Read More